Replies to post #6513 on Sorrento Therapeutics Inc (SRNE)

[qsachse]

Biotech is never a short term play unless you're day trading. If you truly do your DD on this company, you will realize that early summer '21 is when this stock will truly pay off. The real money for sorrento is in their cancer and pain lines. True, the covid portfolio could jumpstart their revenue generation, however, covid will fade in time, and the long term value is in the other portfolios.

[Ganz]

Jess, I know it can be frustrating, but you have to remember, SRNE was largely a pain management/ cancer play when Covid came along.SRNE doesn’t have the reputation and resources of a big pharma company so they constantly have to prove themselves. Ji made some bold statements and lost a lot of respect for dumping his CFO without explanation and the market is getting bearish on this behavior, just think of INO..The truth is , you have to believe in Ji to stay long, which can be trying, if your really in doubt, maybe ring the register on half of your position since most of us got in at $4.I’m holding long though and agree with Q on this as a long term play with a potential Covid pop in the near future.